Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. RIMACTAN (rifampicine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RIMACTAN (rifampicine)

Medicine - Posted on May 13 2019 - Updated on Jun 12 2019
Active substance (DCI)
  • rifampicine
history (3)
  • 4/17/19

    RIMACTAN (rifampicine)

    Maintien du remboursement dans les mêmes conditions.
    icône flèche
  • 7/1/15

    RIMACTAN (rifampicine)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 10/15/08

    RIMACTAN (rifampicine)

    RIMACTAN (rifampicine)
    icône flèche
Technical information
ATC code
  • J04AB02
Manufacturer
SANDOZ SAS
Presentation

RIMACTAN 300 mg, gélule (code CIS : 66404004) plaquette(s) de 30 gélules - Code CIP : 34009 309 162 9 2

RIMACTAN 300 mg, gélule Boîte de 8 - Code CIP : 309 163-5

All our publications
    Bacterial infections Central nervous system diseases Drug therapy Nervous system diseases - miscellaneous Pulmonary and pleural diseases Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
2CRGcpn04EvbpHxL